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Zhang Y, Wu J, King JH, Huang CL-H, Fraser JA. Measurement and
interpretation of electrocardiographic QT intervals in murine hearts. Am J
Physiol Heart Circ Physiol 306: H1553–H1557, 2014. First published April
4, 2014; doi:10.1152/ajpheart.00459.2013.—Alterations in ECG QT in-
tervals correlate with the risk of potentially fatal arrhythmias, for
which transgenic murine hearts are becoming increasingly useful
experimental models. However, QT intervals are poorly defined in
murine ECGs. As a consequence, several different techniques have
been used to measure murine QT intervals. The present work develops
a consistent measure of the murine QT interval that correlates with
changes in the duration of ventricular myocyte action potentials
(APs). Volume-conducted ECGs were compared with simultaneously
recorded APs, obtained using floating intracellular microelectrodes in
Langendorff-perfused mouse hearts. QT intervals were measured
from the onset of the QRS complex. The interval, Q-APR90, measured
to the time at 90% AP recovery, was compared with two measures of
the QT interval. QT1 was measured to the recovery of the ECG trace
to the isoelectric baseline for entirely positive T-waves or to the
trough of any negative T-wave undershoot. QT2—used extensively in
previous studies—was measured to the return of any ECG trough to
the isoelectric baseline. QT1, but not QT2, closely correlated with
changes in Q-APR90. These findings were confirmed over a range of
pacing rates, in low K concentration solutions, and in Scn5a/
KPQ hearts used to model human long QT syndrome. Application of
this method in whole anesthetized mice similarly demonstrated a
prolonged corrected QT (QTc) in Scn5a/KPQ hearts. We therefore
describe a robust method for the determination of QT and QTc
intervals that correlate with the duration of ventricular myocyte APs
in murine hearts.
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THE DURATION OF VENTRICULAR depolarization and repolarization
is reflected in the ECG QT interval (1, 13). It is important for
the diagnosis of inherited and iatrogenic QT disorders associ-
ated with increased risks of polymorphic ventricular tachycar-
dia or Torsades de Pointes that may present as long or short QT
syndromes. Transgenic mouse hearts have proven increasingly
useful in modeling human cardiac arrhythmic disease. How-
ever, mice differ from humans in aspects of cardiac electro-
physiology that have implications for ECG interpretation. Mu-
rine hearts show shorter electrocardiographic RR intervals,
reflecting higher heart rates (600 beats/min).
Murine QRS-T complexes reflect considerably shorter ac-
tion-potential (AP) waveforms lacking plateau phases, result-
ing in indistinct ST segments and T-waves (12). Nevertheless,
the T-wave is often assumed to end at its return to the
isoelectric baseline (5, 9). However, where the T-wave in some
mouse ECG traces shows an apparent negative undershoot, in
addition to its positive component, this approach would sub-
stantially increase estimates of the QT interval or preclude
determination of QT intervals at high heart rates when the
P-wave often becomes superimposed upon the terminal phase
of the previous negative undershoot (12).
Previous murine studies had adopted different empirical QT
estimation methods, including determining: 1) the time taken to
reach 95% recovery for the ECG deflection to return to baseline
(10); 2) the time to the end of the T-wave, itself defined as the
point at which the T-wave time course deviates from the tangent
to the steepest slope of the time course of T-wave recovery (9); 3)
the time at which the QT segment returns to baseline (3, 6, 9a);
and 4) the point of convergence of T-waves and their first
derivative on a signal-averaged ECG recording (14). These vari-
ous approaches met with variable success, leading to doubts as to
whether ECG analysis of this kind could quantify murine AP
parameters (4).
The present paper develops a simple empirical approach for
measuring the QT interval in mouse ECGs by comparing ECGs
with simultaneous intracellular recordings of AP waveforms in
Langendorff-perfused hearts. It then tests the resulting criteria
over a range of pacing rates, and under conditions of altered
QT interval in low K concentration ([K]) solutions and in
Scn5a/KPQ hearts modeling long QT syndrome. It then
further compares in vitro recordings with QT intervals re-
corded in intact, anesthetized Scn5a/KPQ mice.
METHODS
Experimental animals. Experiments were conducted using wild-
type (WT) and Scn5a/KPQ mice, inbred on a 129/Sv genetic
background, aged 3–6 mo, housed in cages at 21  1°C with 12-h
light/dark cycles. All procedures were performed in institutional
premises, approved under the UK Animals (Scientific Procedures) Act
(1986), under UK Home Office project licence PPL number 80/1974,
approved by a university Ethics Review Board. Accordingly, proce-
dures were also in conformity with the Guide for the Care and Use of
Laboratory Animals, published by the U.S. National Institutes of
Health (NIH publication number 85-23, revised 1996).
Simultaneous epicardial ventricular AP and volume-conducted
electrocardiographic recordings from intact Langendorff-perfused
hearts. Mice were killed by cervical dislocation [Schedule 1: UK
Animals (Scientific Procedures) Act 1986]. Their aortas were cannu-
lated, and the heart was perfused at a constant flow rate of 3 ml/min
(Bredel peristaltic pumps, model 505S; Watson-Marlow, Falmouth,
Cornwall, UK) with Krebs-Henseleit (KH) solution (in mM: NaCl
119, NaHCO3 25, KCl 4, KH2PO4 1.2, MgCl2 1, CaCl2 1.8, glucose
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10, Na-pyruvate 2, pH adjusted to 7.4), bubbled with 95% O2/5% CO2
(British Oxygen, Manchester, UK) on a Langendorff system. The KH
solution was passed through a 5-m filter (Millipore, Watford, UK)
and warmed to 37°C using a water jacket and circulator (model
C-85A; Techne, Cambridge, UK). Hearts were laid down with their
anterior surfaces facing upward in a homemade, warmed bath chamber.
Only hearts that regained their pink color and showed 1:1 atrioventricular
conduction with intrinsic activity and after 10–15 min perfusion for
stabilization were then subjected to further electrophysiological testing.
A floating microelectrode holder was constructed from a thin, coiled
silver wire (0.4 mm in diameter) and connected to a 2-mm connecter. A
glass micropipette was drawn from borosilicate glass to a very fine tip and
filled immediately before use with 3 M KCl. The pipette was cut above
its shoulders, and the remaining shank was discarded. The microelectrode
resistances were 15–25 M. The chlorided end of the silver wire was
inserted into the micropipette, with which impalements were made close
to the midpoint between ventricular apex and base, and connected to a
high-input impedance direct-current microelectrode amplifier system
(University of Cambridge, Cambridge, UK). The signals were displayed,
digitized, and analyzed using Spike2 (Cambridge Electronic Design,
Cambridge, UK). Conversion of the analog input to digital signals was
performed using a model Micro1401 interface (Cambridge Electronic
Design) connected to an IBM-compatible computer. Spike2 software
(Cambridge Electronic Design) was used to record and subsequently
analyze ECG recordings. The entire apparatus was mounted on a vibra-
tion-isolation platform in a grounded Faraday cage. APs showing straight
upstrokes, with AP amplitudes 75 mV, maximum rates of rise 85
mV/ms, and resting potentials between80 and65 mV, were used for
further analysis.
Volume-conducted ECGs were recorded simultaneously with the
AP recordings. Three-needle electrodes were immersed in the super-
fused bath flanking the isolated heart. Signals were amplified and
filtered by a model NL104A amplifier (NeuroLog; Digitimer, Hert-
fordshire, UK) and a model NL125/126 filter (set to a bandwidth of
10–5,000 Hz). Conversions of analog input to digital form used a
model 1401 interface (Cambridge Electronic Design) connected to
an IBM-compatible computer. Spike2 software (Cambridge Elec-
tronic Design) was used to record and subsequently analyze ECG
recordings.
An initial series of experiments studied hearts in sinus rhythm.
Further experiments assessed the ECG measured under conditions of
regular stimulation at cycle lengths (CL) of 200, 167, and 143 ms, at
which 50 APs were recorded for each CL. This used a bipolar,
platinum-stimulating electrode (1 mm interpole spacing) placed
against the right atrial epicardium, delivering square-wave stimuli
(Grass S48 stimulator; Grass-Telefactor, Slough, UK) of 2-ms dura-
tion and amplitudes of twice diastolic excitation threshold. The
experiments also examined the effect of reducing the extracellular
[K] from normokalemic (4 mM) to hypokalemic (3 mM) levels in
the KH perfusate to investigate the effects of conditions that would
prolong the QT interval and its measurement.
Measurements from the ECG and intracellular AP traces. The
duration of ventricular electrophysiological activity was determined
by three measurements from the ECG and the AP traces. In each case,
peaks and recovery times were obtained from direct readouts from
successive averages of five data points, obtained by software cursors
successively moved along the time axis. In the ECG traces, the
position of the isoelectric baseline was defined as falling between
the end of the upright P-wave and the beginning of the QRS in the
volume-conducted ECGs, as on previous occasions (15). The begin-
ning of ventricular electrical activity was defined by the onset of the
QRS in the ECG trace, where it deviated from this isoelectric baseline.
The QT interval was then calculated by two methods. 1) QT1 was
measured to the time at which the ECG trace first reached its
minimum value; this was the isoelectric baseline when the T-wave
only showed positive components or the point of maximum under-
shoot where records showed a negative undershoot. 2) QT2 was
defined as the time at which the T-wave reached the isoelectric
baseline. 3) For comparison with ECG records, the Q-APR90 was
defined as the time intervening between the start of the ECG QRS
complex and the time of the APR90, the point of 90% recovery of the
ventricular AP from its peak to the isoelectric baseline in the intra-
cellular microelectrode recordings. Corrected QT (QTc) intervals
were then obtained using the formula QTc 	 QT/(RR/100)1/2 to give
QTc1, QTc2, and Q-APR90c respectively (11).
In vivo ECG recordings from mice under terminal anesthesia.
Independent, in vivo ECG studies were performed on mice anesthetized
with a dose of 0.10 ml/10 g body wt of either: 1) a solution comprising
1.8 ml of 100 mg/ml ketamine hydrochloride (Ketaset; Fort Dodge
Animal Health, Southampton, UK), 0.35 ml of 23.32 mg/ml xylazine
hydrochloride (Rompun; Bayer, Leverkusen, Germany), and 2.85 ml of
sterile phosphate-base solution or 2) 24 mg/ml ip Avertin (2,2,2-tribro-
moethanol; Sigma, Poole, Dorset, UK) into the left peritoneal cavity,
respectively, 15 and 5 min before recording. The anesthetized mice were
placed on a heating pad with continuous monitoring of body temperature
for three-lead ECG measurements in lead II for over 10 min using
subcutaneous needle electrodes and a PowerLab 26T system (ADInstru-
ments, Oxfordshire, UK). Recordings (16 bit, 2 kHz/channel) were
analyzed using the Chart v6.0 program (ADInstruments). Recordings
were filtered between 0.5 and 500 Hz.
Data analysis and statistics. Data are expressed as means  SE.
The numbers (n) denote either numbers of whole hearts or the number
of cells. The sets of data were compared using ANOVA with post hoc
Tukey’s honestly significant difference test, as well as regression
analysis (SPSS software; SPSS, Chicago, IL). P 
 0.05 was consid-
ered statistically significant.
RESULTS AND DISCUSSION
Figure 1 displays typical ECGs from a range of Avertin-
anesthetized mice studied under similar conditions. Isoelectric
Fig. 1. ECG patterns from anesthetized mice show marked variability. A:
recorded from a wild-type (WT) mouse; the QRS-T complex ends with an
upright T-wave that then returns to the isoelectric baseline (arrow). B: recorded
from an Scn5a/KPQ mouse; the positive part of the T-wave is followed by
a negative undershoot before returning (arrow) to the isoelectric baseline
(dashed line). C: recorded in a WT mouse, 10 min after administration of
isoprenaline (2.0 mg/kg ip); the T-waves show negative undershoot compo-
nents, not fully separable from the succeeding P-waves.
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baselines were determined between the end of the P-wave and
the beginning of the QRS (16). The beginning of ventricular
electrical activity was defined by the beginning of the QRS
complex. As reported previously in both mouse and rat, the
beginnings of the T-waves were often indistinct, likely reflect-
ing short or absent AP plateau phases (12, 17).
Figure 1A shows an upright ECG T-wave with a clear-cut
decay to isoelectric baseline. In contrast, in Fig. 1B, the
positive component of the T-wave was followed by a pro-
longed, negative undershoot. Inclusion of the latter waveform
would thus substantially increase estimates of the QT interval
(40 ms vs. 130 ms, respectively). Figure 1C shows T-waves
with negative undershoot components, not clearly separable
from the succeeding P-waves, which would complicate deter-
mination of the end of the T-wave.
Figure 2A compares typical intracellular ventricular APs (a),
obtained in WT hearts, with simultaneously recorded, volume-
conducted ECGs (b). The latter showed positive-going T-
waves, followed by direct decays [Fig. 2A, (i)] or by prolonged,
negative undershoots [Fig. 2A, (ii)]. Different definitions of the
QT interval, as depicted by the cursors, were compared with
predictions from AP recordings. Thus cursor 1 shows Q-
APR90 in the AP trace. Cursor 2 depicts QT1, extending to the
point at which the ECG trace regained the isoelectric baseline
in records where the T-wave only showed positive components
or where any prolonged, negative undershoots reached their
minima. In this example, QT1 was in agreement with Q-APR90
in each case [within9.8 ms in Fig. 2A, (ii)]. In contrast, QT2,
which extended to full recovery to the isoelectric baseline
(cursor 3), gave marked 104.7-ms differences from Q-APR90
with the waveform depicted in Fig. 2A, (ii).
Figure 2B plots QT1 and QT2 against Q-APR90 in each of
24 myocytes from eight WT hearts, including means and SE of
the mean where the latter exceeded the sizes of the data points
themselves. Each point shows ECG and intracellular AP pa-
rameters obtained simultaneously and averaged over the full
duration of each successful cell impalement. The regression
lines showed that QT1 closely correlated with Q-APR90 [QT1 	
0.986  Q-APR90; regression coefficient (r) 	 0.863]. In
contrast, QT2 values correlated poorly with Q-APR90 (QT2 	
2.15  Q-APR90; r 	 0.618), as demonstrated previously (4).
Figure 2C illustrates the closeness or otherwise of
Q-APR90c, QTc1, and QTc2 for each of the eight hearts that
were studied. In each of these individual hearts, Q-APR90c and
QTc1 values were statistically indistinguishable (P  0.05,
n 	 8). In contrast, QTc2 values were consistently larger than
Fig. 2. Relationships between intracellular action-potential (AP) duration and volume ECG QT intervals in WT hearts. A, (i) and (ii): APs (a) and the
corresponding ECG recordings (b). Cursor 1 indicates the AP at 90% recovery (Q-APR90). Cursor 2 is placed at the minimum value of a late negative undershoot
(QT1). Cursor 3 indicates the point where the undershoot component regains the isoelectric baseline (QT2). V, volts. B: plots of QT1 and QT2 intervals against
Q-APR90 values observed and their respective regression lines. C: summarization of corrected Q-APR90 (Q-APR90c) and corrected QT1 and QT2 (QTc1 and
QTc2, respectively), resulting from 8 individual hearts. Results from hearts 1–8 were obtained in the course of recording from n 	 6, 4, 3, 1, 5, 1, 1, and 3 cells,
respectively, of which, ECG records in hearts 2 and 6 showed a kinetic pattern, generally similar to that in A, (i), b, whereas the remainder showed more complex
kinetic patterns similar to that in A, (ii), b. D: summarization of mean (SE) Q-APR90c, QTc1, and QTc2 values. **P 
 0.01.
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both Q-APR90c and QTc1 (Fig. 2C). Concordant results
emerged from comparisons between Q-APR90c and QTc1
(P  0.05) but not between these measures and QTc2 (P 

0.01 in both cases) over the entire set of hearts (Fig. 2D).
Hence, QTc1 correlated well with Q-APR90c over a wide range
of values, whereas QTc2 is larger than Q-APR90c and corre-
lates with it poorly, especially when the T-wave has negative
components.
Measurements of Q-APR90, QT1, and QT2 intervals, aver-
aged over 50 beats, were then repeated during pacing at CL of
200, 167, and 143 ms. Means and SE at the three pacing rates
were similar for Q-APR90 (41.04  0.09, 41.55  0.05, and
41.02  0.04 ms, respectively) and QT1 (42.78  0.17, 42.47 
0.19, and 41.66 0.46 ms). In contrast, both means and the SE
of QT2 varied markedly at the three pacing rates (109.56 
0.74, 101.76  0.77, and 73.03  0.58 ms, respectively) and
differed significantly from Q-APR90 in each case.
Further measurements of Q-APR90, QT1, and QT2 were
made before and after acute alterations in AP durations, pro-
duced by replacing normokalemic with hypokalemic perfusate,
previously shown to produce prolongation of AP duration as
recorded using monophasic AP electrodes (8). Hypokalemia
increased Q-APR90 from 40.89  1.08 (four cells in one heart)
to 44.27  0.72 ms, respectively (eight cells in one heart).
Simultaneously recorded QT1 values similarly increased, from
41.02  2.49 to 53.08  0.37 ms. In contrast, the correspond-
ing QT2 values reduced from 95.79  3.22 to 89.00  3.89
ms, respectively.
QT intervals were then quantified in murine Scn5a/KPQ
hearts containing the KPQ (1,505–1,507) gain-of-function
Scn5a deletion, modeling human long QT syndrome and ex-
pected to demonstrate chronic QT-interval prolongation (7,
18). Ventricular APs were obtained from 40 cells in three
Scn5a/KPQ hearts. An example is shown in Fig. 3A, (ii),
for comparison with a WT recording [Fig. 3A, (i)]. These
showed greater AP durations than WT (Q-APR90c values of
41.47  3.37 in Scn5a/KPQ vs. 36.33  1.45 in WT, P 

0.05). Simultaneously recorded, volume-conducted ECGs sim-
ilarly demonstrated increased values of QTc1 (43.58  4.22)
and QTc2 (111.3  5.91) relative to WT [35.99  1.33 (P 

0.05) and 66.92  6.21 (P 
 0.01), respectively]. As for the
WT hearts (Fig. 2), mean QTc1 values in Scn5a/KPQ
hearts (Fig. 3C) were not significantly different from
Q-APR90c (43.58 4.22 vs. 41.47 3.37, P 0.05), whereas
their mean QTc2 value (111.3  5.91) was significantly larger
than both Q-APR90c and QTc1 (P 
 0.01 in each case).
Finally (Table 1), ECGs were recorded from intact, anesthe-
tized—as opposed to isolated, perfused—Scn5a/KPQ and
WT mice. These were statistically indistinguishable (P 0.05)
within groups under either Avertin (n 	 19 and 26, respec-
tively) or ketamine anesthesia (n 	 10 and 23). However,
Scn5a/KPQ showed consistently greater QTc1 than WT
(44.56 2.23 and 45.42 3.00 in Scn5a/KPQ vs. 33.60
1.87 and 30.75  1.50 ms in WT, P 
 0.05 in both cases), in
agreement with findings in isolated, perfused hearts.
Fig. 3. Relationships between intracellular
AP duration and volume ECG QT intervals
in Scn5a/KPQ hearts. A: comparison of
simultaneous recordings of a typical AP
from a single ventricular myocyte (a) with
the corresponding ECG trace (b) from WT
(i) and Scn5a/KPQ (ii). B: comparison of
Q-APR90c, QTc1, and QTc2 in individual
Scn5a/KPQ hearts. C: summarization of
mean (SE) Q-APR90c, QTc1, and QTc2
values. **P 
 0.01.
Table 1. Summary comparing QTc intervals in anesthetized
mice during ECG recordings
Condition Genotype n 	 Hearts QTc, ms
Avertin WT 26 33.60 1.87*
Scn5a/KPQ 19 44.56  2.23*
Ketamine WT 23 30.75 1.50†
Scn5a/KPQ 10 45.42  3.00†
Note that similar symbols differ from each other at P
 0.05. QTc, corrected
QT; WT, wild-type.
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Thus the time from the start of ventricular activity to the
time of minimum voltage (QT1) is a stable and repeatable
measurement of the murine QT interval that correlates with the
duration of intracellularly recorded APs.
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